We carried out a questionnaire survey to assess adherence of inhalers in asthmatic patients treated with fluticasone/salmeterol Discus(FP/SM-DK)or budesonide/formoterol Turbuhaler(BUD/FM-TH). FP/SM-DK was significantly more favorable than BUD/FM-TH about the questions about inhaler treatment adherence and inhalation feeling. In addition, ACT and spirometric assessment did not change 4 and 12 weeks after changing from BUD/FM-TH 640/18μg/day to FP/SM-DK 500/100μg/day in 11 symptomatic patients treated with BUD/FM-TH. In conclusion, FP/SM-DK seems to have more favorable adherence than that of BUD/FM-TH.


電子版ISSN 印刷版ISSN 1344-6932 医薬ジャーナル社